Topics

Sanjiv S. Shah, M.D., Appointed Chief Medical Officer of MetroPlus Health Plan

11:57 EDT 13 Aug 2019 | Businesswire

The Board of MetroPlus Health Plan today announced the appointment of Sanjiv S. Shah, M.D. as the health plan’s new Chief Medical Officer (CMO). As the health plan owned by NYC Health + Hospitals with more than half a million members in the five boroughs, MetroPlus is a vital part of New York City’s initiative to guarantee health care to all New Yorkers. Dr. Shah assumed his new position on August 12.

“I am delighted to announce Dr. Shah’s appointment as Chief Medical Officer. We are confident Dr. Shah is the visionary leader we need to continue ensuring our members receive the excellent health services they deserve and continue to rank us among the top in quality and patient satisfaction,” said MetroPlus Board Chair Sally Hernandez-Piñero.

“It is an honor to assume this role and, in close collaboration with NYC Health + Hospitals, be able to be of service to so many New Yorkers,” said Dr. Sanjiv S. Shah. “MetroPlus has been providing affordable, high quality health coverage to New Yorkers, regardless of their situation, since 1985. I am proud to support the plan’s mission of inclusive, person-centered, quality-driven care, and look forward to providing excellent access to medical care to our more than 500,000 members.”

Dr. Shah has more than 20 years of experience as a physician leader, managed care executive, and infectious disease specialist. He joins MetroPlus from the Mount Sinai Health System where he served as Medical Director. He also served as Chief Medical Officer at Fidelis Care and Deputy Chief Medical Officer and Associate Medical Director of HIV Services at MetroPlus.

Dr. Shah earned his medical degrees from University of Nottingham School of Medicine in the UK and a Master of Public Health in Epidemiology from the Mailman School of Public Health at Columbia University. He completed his residency at Mount Sinai, served as Chief Medical Resident at NYC Health + Hospitals/Elmhurst, and was a Fellow in Infectious Diseases at the Albert Einstein College of Medicine and Montefiore Medical Center. Dr. Shah has published and presented extensively on numerous medical issues both nationally and abroad.

About MetroPlus

MetroPlus Health Plan offers eligible New Yorkers a wide selection of health insurance options, including Medicaid, Medicare, Child Health Plus, MetroPlus Gold for city employees and SHOP for small businesses. The health plan offers access to primary, specialty, pharmacy and other health care services at low or no cost throughout New York City for people of all ages and varied health needs. MetroPlus members enjoy special perks including up to $1,000 in gym reimbursement, a rewards points program to redeem for gifts, and services to address social determinants of health like housing and food insecurity.

Since 1985, MetroPlus Health Plan has built a reputation for providing access to affordable, quality health care to residents of Brooklyn, the Bronx, Manhattan, Queens and Staten Island. A wholly-owned subsidiary of NYC Health + Hospitals, the nation’s largest public health system, MetroPlus is the plan of choice for over half a million New Yorkers and has a five-star rating based on the State’s 2018 Consumer’s Guide to Medicaid and Child Health Plus Managed Care Plans in New York City. The health plan’s robust network of primary care doctors and specialists includes many independent community providers. Culturally sensitive, and fluent in more than 40 languages, MetroPlus staff is as diverse as the great city it serves. For more information about MetroPlus plans, benefits, and services, visit www.metroplus.org and join the conversation at facebook.com/metroplushealth and twitter @metroplushealth.

 

Kathryn Knox Soman
212-908-8588
somank@metroplus.org

NEXT ARTICLE

More From BioPortfolio on "Sanjiv S. Shah, M.D., Appointed Chief Medical Officer of MetroPlus Health Plan"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...